Bone marrow transplantation versus chimeric antigen receptor T cells (CAR-T) therapy for hematological malignancies

Outros usuários também visualizaram estes artigos

Reduced Intensity Conditioning for Allogeneic Stem Cell Transplantation (HSCT) in Acute Myeloid Leukemia Arnon Nagler;

Hematol Transfus Cell Ther. 2022;44 Supl 1:S5

HAPLOIDENTICAL VERSUS UNRELATED ALLOGENEIC STEM CELL TRANSPLANTATION FOR ADULTS WITH ACUTE LEUKEMIA Arnon Nagler;

Hematol Transfus Cell Ther. 2021;43 Supl 3:S4-5

Update on chimeric antigen receptor ¿ T cells (CAR-T) CD19 therapy: the Sheba experience Arnon Nagler;

Hematol Transfus Cell Ther. 2020;42 Supl 1:7-8